IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Aug 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-08-03

Reporting Person: TWIGGE GIOVANI (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-03	Common Stock	M	1476	$67.85	Acquired	18447.4780	Direct
2021-08-03	Common Stock	M	8874	$141.60	Acquired	27321.4780	Direct
2021-08-03	Common Stock	S	7036	$695.3375	Disposed	20285.4780	Direct
2021-08-03	Common Stock	S	1838	$696.3205	Disposed	18447.4780	Direct
2021-08-04	Common Stock	M	5141	$178.26	Acquired	23588.4780	Direct
2021-08-04	Common Stock	M	3068	$206.94	Acquired	26656.4780	Direct
2021-08-04	Common Stock	M	1893	$288.78	Acquired	28549.4780	Direct
2021-08-04	Common Stock	S	1319	$700	Disposed	27230.4780	Direct
2021-08-04	Common Stock	S	9242	$700.3027	Disposed	17988.4780	Direct
2021-08-04	Common Stock	S	860	$701.3608	Disposed	17128.4780	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-03	Incentive Stock Option (right-to-buy)	$67.85	M	1476	Disposed	2026-02-13	Common Stock (1476)	Direct
2021-08-03	Non-Qualified Stock Option (right-to-buy)	$141.60	M	8874	Disposed	2027-02-13	Common Stock (8874)	Direct
2021-08-04	Non-Qualified Stock Option (right-to-buy)	$178.26	M	5141	Disposed	2028-02-13	Common Stock (5141)	Direct
2021-08-04	Non-Qualified Stock Option (right-to-buy)	$206.94	M	3068	Disposed	2029-02-13	Common Stock (3068)	Direct
2021-08-04	Non-Qualified Stock Option (right-to-buy)	$288.78	M	1893	Disposed	2030-02-13	Common Stock (1893)	Direct

Footnotes

F1: Includes a total of 21.4780 shares of common stock acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021.

F2: Represents the weighted average price of the shares sold ranging from a low of $695.00 to a high of $695.995 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F3: Represents the weighted average price of the shares sold ranging from a low of $696.02 to a high of $696.78 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F4: Represents the weighted average price of the shares sold ranging from a low of $700.00 to a high of $700.995 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F5: Represents the weighted average price of the shares sold ranging from a low of $701.05 to a high of $701.91 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F6: Grant of option to buy 1,476 shares of Issuer common stock that vested as to 1 share on February 14, 2017, February 14, 2018 and February 14, 2020, respectively, and as to the remainder on February 14, 2021.

F7: Grant of option to buy 10,386 shares of Issuer common stock that vest in five annual installments beginning February 14, 2018.

F8: Grant of option to buy 8,007 shares of Issuer common stock that vest in five annual installments beginning February 14, 2019.

F9: Grant of option to buy 7,186 shares of Issuer common stock that vest in four annual installments beginning February 14, 2020.

F10: Grant of option to buy 7,570 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021.

F11: Not applicable.